This page shows the latest Tukysa news and features for those working in and with pharma, biotech and healthcare.
added. Last week, the European Commission also approved Tukysa in the HER2-positive advanced breast cancer setting. ... The EC approval for Tukysa is valid in Northern Ireland, while the MHRA authorisation covers England, Scotland and Wales.
In addition to the commercialisation agreement, Merck will also co-fund a portion of the Tukysa global development plan, which includes several ongoing and planned trials across HER2-positive cancers. ... Tukysa was approved by the US Food and Drug
If approved will compete with AZ/Daiichi Sankyo's Enhertu
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Founded in 2015, Windrose Consulting Group is a privately-held global strategy firm that partners with life science companies to maximize...